Wela Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$743K Sell
4,004
-156
-4% -$26.7K 0.28% 28
2025
Q2
$635K Buy
4,160
+241
+6% +$37K 0.25% 32
2025
Q1
$650K Buy
3,919
+444
+13% +$69.5K 0.27% 27
2024
Q4
$503K Buy
3,475
+525
+18% +$81.4K 0.22% 35
2024
Q3
$478K Buy
2,950
+124
+4% +$19.8K 0.21% 32
2024
Q2
$413K Buy
2,826
+93
+3% +$13.8K 0.19% 38
2024
Q1
$432K Buy
2,733
+104
+4% +$16.6K 0.2% 36
2023
Q4
$412K Buy
2,629
+378
+17% +$58K 0.22% 36
2023
Q3
$351K Buy
+2,251
New +$371K 0.21% 37

Other funds holding JNJ

Wela Strategies's JNJ Position: Q3 2025 in Review

Wela Strategies reduced its Johnson & Johnson (JNJ) stake by 3.8% in Q3 2025, selling an estimated $26.7K and leaving 4,004 shares worth $743K. The position accounts for 0.28% of the portfolio, ranked #28.

Wela Strategies first reported a position in JNJ in Q3 2023 and has held it in 9 quarters since. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Wela Strategies held 4,004 shares of Johnson & Johnson worth $743K as of Q3 2025.
  • Wela Strategies sold 156 Johnson & Johnson shares in Q3 2025, an estimated $26.7K.
  • Johnson & Johnson made up 0.28% of Wela Strategies's portfolio in Q3 2025, its #28 holding.
  • Wela Strategies first reported a position in Johnson & Johnson in Q3 2023 and has held it in 9 quarters since.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Wela Strategies's 13F filing for Q3 2025, filed 24 Oct 2025.